Excited to share our new paper in Science Translational Medicine! In our work we identified the ECM as a potential target to treat metastatic melanoma by targeting LOX and HSP70 with biselective LOX-propeptide decoys. Congrats to @irit_irit@LevyCarmit@LabSagi@MatrxBiomeLab
Self-Immolative Dendrimers are now being applied as a linker technology for ADC. Rewarding collaboration with @RSFLab and Merck KGaA:
https://t.co/7QYyHYxEzs
Instead of living a normal student's life, and focusing on her PhD, Nofar is fighting for her brother's return from captivity ๐ #BringThemHomeNow#Hamas_is_ISIS@TelAvivUni